Judith A. Wilimas, MD

    Judith A. Wilimas, MD

    Member, St. Jude Faculty
    Medical Director, Referring Physicians Office and Affiliate Program



    Contact Information

    Judith Wilimas, MD
    Domestic Affiliates
    MS 722, Room R3040
    St. Jude Children's Research Hospital
    262 Danny Thomas Place
    Memphis, TN 38105-3678
    Email: judy.wilimas@stjude.org
    Phone: (901) 595-4641
    FAX: (901) 595-4372


    MD - Wayne State University School of Medicine, Detroit, Michigan (1970)

    Research Interests

    Selected Publications

    Day SW, Garcia J, Antillon F, Wilimas JA, McKeon LM, Carty RM, de Alarcon P, Pui C-H, Ribeiro RC, Howard SC. A Sustainable Model for Pediatric Oncology Nursing Education in Low-Income Countries. Pediatric Blood and Cancer 58:163-166, 2012.

    Whittle S, Gosain A, Scott Brown PY, Debelenko L, Raimondi S, Wilimas JA, Jenkins JJ, and Davidoff AM. Regression of a Congenital Mesoblastic Nephroma. Pediatric Blood and Cancer 55(2):364-368, 2010.

    Maurer SH, Wilimas JA, Wang WC, Reiss UM. Heparin Induced Thrombocytopenia and Re-Thrombosis Associated with Wafarin and Fondaparinux in a Child. Pediatric Blood and Cancer 53(3):468-471, 2009.

    Baskin JL, Pui CH, Reiss U, Wilimas JA, Metzger ML, Ribeiro RC, Howard SC. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 374:159-169, 2009.

    Wilimas JA, Wilson MW, Haik BG, Barnoya M, Fu L, Castellanos M, Bonilla M, Phillips B, Helveston EM, Luna-Fineman S, Ribeiro R, Rodriguez-Galindo C. Development of retinoblastoma programs in Central America. Pediatr Blood Cancer Mar 26, 2009. [Epub ahead of print]

    Daw NC, Gregornik D, Rodman J, Marina N, Wu J, Kun LE, Jenkins JJ, McPherson V, Wilimas J, Jones DP. Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour. Eur J Cancer Jan;45(1):99-106, 2009. Epub 2008 Nov 6.

    Rodriguez-Galindo C, Wilson MW, Chantada G, Fu L, Qaddoumi I, Antoneli C, Leal-Leal C, Sharma T, Barnoya M, Epelman S, Pizzarello L, Kane JR, Barfield R, Merchant TE, Robison LL, Murphree AL, Chevez-Barrios P, Dyer MA, O’Brien J, Ribeiro RC, Hungerford J, Helveston EM, Haik BG, Wilimas J. Retinoblastoma: One World, One Vision. Pediatrics 122;e763-e770, 2008.

    Howard SC, Metzger ML, Wilimas JA, Quintana Y, Pui CH, Robison LL, Ribeiro RC. Childhood cancer epidemiology in low-income countries. Cancer Dec 10, 2007 Epub

    Wilimas JA. Iron deficiency. Ped Blood Cancer 48: 491-2, 2007.

    Leander C, Fu L, Peña A, Howard SC, Rodriguez-Galindo C, Wilimas J, Ribeiro R, Haik B. Education expedites retinoblastoma diagnosis. Ped Blood Cancer Sep 28, 2007 [Epub ahead of print].

    Ayoub L, Fu L, Pena A, Sierra JM, Dominguez PC, Pui CH, Quintana Y, Rodriguez A, Barr RD, Ribeiro RC, Metzger ML, Wilimas JA, Howard SC. Implementation of a data management program in a pediatric cancer unit in a low income country. Ped Blood Cancer Jul 21, 2006 [Epub ahead of print].

    Howard SC, Campana D, Coustan-Smith E, Antillon FG, Bonilla M, Fu L, Pui C-H, Ribeiro RC, Wilimas JA, Lorenzana R. Development of a regional flow cytometry center for diagnosis of childhood leukemia in Central America. Leukemia 19: 323-325, 2005.

    Howard SC, Wilimas JA, Delays in diagnosis and treatment of childhood cancer: Where in the world are they important? Ped Blood Cancer 44(4): 303-304, 2005.

    Corey B, Yang CH, Wilimas JA, Davidoff A, Dome JS. Significance of pleural effusion at diagnosis of Wilms tumor. Ped Blood Cancer 42(2): 145-8, 2004.

    Wilimas JA, Donahue N, Chammas G, Fouladi M, Bowers LJ, Ribeiro RC. Training subspecialty nurses in developing countries: Methods, outcome and cost. Med Ped Oncol 41: 136-140, 2003.

    Metzger ML, Howard SC, Fu LC, Pena A, Stefan R, Hancock ML, Zhang Z, Pui CH, Wilimas J, Ribeiro RC. Outcome of childhood acute lymphoblastic leukaemia in resource-poor countries. Lancet 362: 706-708, 2003.

    Dome JS, Liu T, Krasin M, Lott L, Shearer P, Daw NC, Billups CA, Wilimas JA. Improved Survival for patients with recurrent Wilms tumor: the experience at St. Jude Children’s Research Hospital. J Pediatr Hematol Oncol 24(3):192-8, 2002.

    Wilimas JA, Ribeiro RC. Pediatric Hematology-oncology Outreach for Developing Countries. Hematol Oncol Clin North Am 15(4):775-787, 2001.

    Venkateswaran L, Wilimas JA, Dancy R, Wang WC. Granulocyte-macrophage colony-stimulating factor in the treatment of neonates with neutropenia and sepsis. Pediatr Hematol Oncol 17(6):469-73, 2000.

    Pedrosa F, Bonilla M, Liu A, Smith K, Davis D, Ribeiro RC, Wilimas JA. Effect of malnutrition at the time of diagnosis on the survival of children treated for cancer in El Salvador and Northern Brazil. J Pediatr Hematol Oncol 22(6):502-5, 2000.

    Daw NC, Wilimas JA, Wang WC, Presbury GJ, Joyner RE, Harris SC, David Y, Chen G, Chesney J. Nasopharyngeal carriage of penicillin-resistant streptococcus pneumoniae in children with sickle cell disease. Pediatrics 99(4), 1997.

    Wang WC, Wong W-Y, Rogers ZR, Wilimas JA, Buchanan GR, Powars DR. Antibiotic-resistant pneumococcal infection in children with sickle cell disease in the United States. J Pediatr Hematol Oncol 18:140-144, 1996.

    Chesney PJ, Wilimas JA, Presbury G, Abbasi S, Leggiadro RJ, Davis Y, Day SW, Schutze GE, Wang WC. Penicillin and cephalosporin-resistant strains of Streptococcus pneumoniae causing sepsis and meningitis in children with sickle cell disease. J Pediatr 127:526-532, 1995.

    Wilimas JA, Wall JE, Fairclough DL, Dancy R, Griffin C, Karanth S, Wang W, Evans W. Longitudinal study of granulocyte-colony stimulating factor and neutrophil count in newborn infants. Am J Pediatr Hematol Oncol 17(2):176-179, 1995.

    Lane PA, Rogers ZR, Woods GM, Wang WC, Wilimas JA, Miller ST, Khakoo Y, Buchanan GR. Fatal pneumococcal septicemia in hemoglobin SC disease. J Pediatr 124:859-862, 1994.

    Wilimas JA, Flynn PM, Harris S, Day S, Smith R, Chesney PJ, Rodman J, Eguiguren J, Fairclough D, Wang WC. Safety and effectiveness of outpatient treatment with ceftriaxone for febrile children with sickle cell disease. N Engl J Med 329:472-476, 1993.

    Last update: February 2013